GSK RSV Ad - Search Videos

GlaxoSmithKline TV Spot, 'Cut Short by RSV: Learning'

GlaxoSmithKline TV Spot, 'Cut Short by RSV: Learning'

GlaxoSmithKline TV Spot, 'Cut Short by RSV: Showing Up'

GlaxoSmithKline TV Spot, 'Cut Short by RSV: Showing Up'

FDA Approves GSK’s RSV Vaccine for Older Adults

FDA Approves GSK’s RSV Vaccine for Older Adults

GlaxoSmithKline TV Spot, 'Cut Short by RSV'

GlaxoSmithKline TV Spot, 'Cut Short by RSV'

GlaxoSmithKline TV Spot, 'Cut Short by RSV: Outings'

GlaxoSmithKline TV Spot, 'Cut Short by RSV: Outings'

We're committed to help raise awareness among those who are most at risk of RSV, especially older adults and those with health conditions. Safeguard yourself and your loved ones this holiday season by consulting your healthcare professional and learning how you can help reduce the risk of developing an RSV infection. Together, let's ensure everyone can enjoy a great holiday! | GSK

We're committed to help raise awareness among those who are most at risk of RSV, especially older adults and those with health conditions. Safeguard yourself and your loved ones this holiday season by consulting your healthcare professional and learning how you can help reduce the risk of developing an RSV infection. Together, let's ensure everyone can enjoy a great holiday! | GSK

1.4K viewsDec 22, 2023

RSV causes approximately 177,000 hospitalisations and an estimated 14,000 deaths in adults aged 65 years and older in the US each year. For adults 60 and older, some data suggest that there is an increased risk for severe RSV infection that can lead to hospitalisation. Although the symptoms of RSV infection are typically mild, older adults, and those with underlying medical conditions such as chronic heart and lung diseases, are at increased risk of severe infection. Find out how we’ve been tryi

RSV causes approximately 177,000 hospitalisations and an estimated 14,000 deaths in adults aged 65 years and older in the US each year. For adults 60 and older, some data suggest that there is an increased risk for severe RSV infection that can lead to hospitalisation. Although the symptoms of RSV infection are typically mild, older adults, and those with underlying medical conditions such as chronic heart and lung diseases, are at increased risk of severe infection. Find out how we’ve been tryi

1.5K viewsJul 14, 2023

GSK - rsv commecial old people 60 cut for load green

1.1K views10 months ago

YouTubeHarry little guy

GSK “Cut short by RSV” RSV and Me commercial (2023)

Our immune systems weaken as we age, making us more vulnerable to infections like respiratory syncytial virus (RSV), which can pose significant health risks. Hear how RSV impacted Peter’s life. | GSK

1.8M viewsAug 23, 2024

FDA advisers recommend world's first RSV vaccines, from Pfizer and GSK

NBC NewsAria Bendix

GSK Shares Slump After CDC Narrows Age Recommendation for RSV Shots

GSK plc Announces Expansion of AREXVY Approval to Adults Aged 18 to 49 Years for RSV Prevention

marketscreener.com

Gsk Plc's Rsv Vaccine Receives European Approval for Expanded Use in All Adults 18 Years and Older

marketscreener.com

RSV (respiratory syncytial virus) usually causes mild, cold-like symptoms, but older adults, including those with certain underlying conditions, are at an increased risk for severe infection. Trademarks owned or licensed by GSK. ©2024 GSK or licensor. NPUS-RSASMP240010 September 2024 Produced in USA. | RSV and Me

9.2M viewsFeb 25, 2025

FacebookRSV and Me

Your risk of infection from respiratory syncytial virus (RSV) can increase due to certain conditions, like some ongoing illnesses or living in long-term care. How many of the below are you familiar with? Do you know someone who might be at risk of RSV? Learn more below 👇 or talk to your healthcare provider about how you can protect yourself and your loved ones from RSV | GSK

423 views8 months ago

GSK and Earvin “Magic” Johnson Partner to Raise Awareness of Risk of RSV in Older Adults

businesswire.com

Understanding respiratory syncytial virus means more than knowing the letters R-S-V. We are on a mission to help improve understanding about this leading cause of respiratory illness. At the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) this week, we will hear from respiratory and immunology experts: Dr Andrea Love and Prof Alberto Papi. Together, we are taking action to improve awareness, help reduce the burden of RSV and support better health outcom

3.2K viewsApr 9, 2025

Understanding respiratory syncytial virus means more than knowing the letters R-S-V. Take a minute to hear some facts about RSV from GSK colleagues and experts in vaccines and respiratory medicine 👇 | GSK

576 views8 months ago

US FDA approves first RSV vaccine from GSK

marketscreener.com

GSK’s vaccine against RSV wins FDA approval

GSK: FDA Accepts Application To Review Expanded Use Of RSV Vaccine, Arexvy

finanznachrichten.de

GlaxoSmithKline TV Spot, 'VRS: trabajar'

GSK, RSV tedavisinde kullanılacak ilk aşı adayının Faz 3 sonuçlarını duyurdu | Sağlık Haberleri

8.3M viewsJul 13, 2022

GSK's Race to Bring an RSV Vaccine to Market

Research and development approach | GSK

GSK “Cut short by RSV” RSV and Me Commercial (2025)

4.4K views8 months ago

YouTubeZHENG WEN

GSK: Does new RSV jab have the edge of Pfizer's vaccine?

proactiveinvestors.co.uk

Ad of the day: GSK India’s ‘Shingles campaign’ with Amitabh Bachchan and Manoj Pahwa

financialexpress.com

GSK's RSV shot cleared in US for all adults #pharma #pharmanews #news

75 views2 months ago

YouTubepharmaphorum media limited

See more